Valeo Pharma (VPHIF) Financial Statements
Valeo Pharma Financial Overview
Valeo Pharma's market cap is currently $3.18M. The company's EPS TTM is $-0.34; its P/E ratio is 0.00; Valeo Pharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Oct 23 | Oct 22 | Jan 22 | Jan 21 | Jan 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 53.91M | $ 27.75M | $ 13.56M | $ 7.47M | $ 6.58M |
| Gross Profit | $ 13.08M | $ 6.28M | $ 3.96M | $ 1.38M | $ 1.40M |
| Operating Income | $ -17.23M | $ -19.60M | $ -12.82M | $ -4.34M | $ -3.54M |
| EBITDA | $ -11.39M | $ -15.73M | $ -10.64M | $ -3.74M | $ -3.41M |
| Net Income | $ -27.81M | $ -25.75M | $ -14.23M | $ -4.76M | $ -3.62M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.50M | $ 22.50M | $ 2.04M | $ 2.84M | $ 335.00K |
| Total Assets | $ 41.21M | $ 58.27M | $ 21.03M | $ 10.96M | $ 5.81M |
| Total Debt | $ 65.17M | $ 61.44M | $ 7.67M | $ 3.26M | $ 1.00M |
| Net Debt | $ 57.67M | $ 38.94M | $ 5.63M | $ 426.00K | $ 666.00K |
| Total Liabilities | $ 81.54M | $ 76.11M | $ 18.98M | $ 7.89M | $ 5.83M |
| Stockholders' Equity | $ -40.34M | $ -17.85M | $ 2.05M | $ 3.07M | $ -22.00K |
| Cash Flow | |||||
| Free Cash Flow | $ -21.25M | $ -35.39M | $ -15.78M | $ -6.70M | $ -3.25M |
| Operating Cash Flow | $ -15.70M | $ -28.50M | $ -12.31M | $ -5.30M | $ -2.31M |
| Investing Cash Flow | $ -5.55M | $ -6.89M | $ -3.46M | $ -1.41M | $ -923.00K |
| Financing Cash Flow | $ 6.19M | $ 54.99M | $ 15.10M | $ 9.21M | $ 3.55M |
Currency in CAD
